your most complete directory for cancer information and medications Click here
kidney disease, cancer symptoms, colon cancer, colon cancer symptoms, colorectal cancer, kidney cancer, lime disease, lip cancer, causes of mouth cancer, leukaplakia, liver cancer, liver cancer symptoms, emphazima, gastric cancer, endometrial cancer, cancer support, cancer therapy, cancer vaccines, cancer treatment, cancer treatments, inflamatory breast cancer, inflammatory breast cancer, esophagus, esophageal cancer, esophagus cancer, cervical cancer early detection, cervical cancer, cervical cancer symptomsStudies indicate that ingested oral cyanocobalamin tablets are ineffective in the treatment of allergic disease, perhaps because once ingested, they are directly metabolized in the liver. When B12 is delivered via injection or lozenge it passes throughout the bloodstream before arriving at the liver. It is during this first pass in its native form that it is believed to exert its therapeutic effect. CLINICAL RESEARCH: "The World Health Organization (WHO) recognizes allergic rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, urticaria, eczema, dermatitis (contact and atopic)...allergic and migraine headache...as diseases in which IgE-mediated allergy may be involved."1 In 1988, asthma and allergic rhinitis subjects were treated with B12. Total IgE, specific IgE and pulmonary lung functions were taken cancersupport at days 45, 150 and 180 from baseline. Eight of the 9 subjects had reduced IgE. 2 In 1989 open label studies at two sites in Riverside County, CA in 1989. Sixteen of the 17 subjects cancersupport had lowered IgE levels from Day 0 to Day 30.3
Studies indicate that ingested oral cyanocobalamin tablets are ineffective in the treatment of allergic disease, perhaps because once ingested, they are directly metabolized in the liver. When B12 is delivered via injection or lozenge it passes throughout the bloodstream before arriving at the liver. It is during this first pass in its native form that it is believed to exert its therapeutic effect. CLINICAL RESEARCH: "The World Health Organization (WHO) recognizes allergic rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, urticaria, eczema, dermatitis (contact and atopic)...allergic and migraine headache...as diseases in which IgE-mediated allergy may be involved."1 In 1988, asthma and allergic rhinitis subjects were treated with B12. Total IgE, specific IgE and pulmonary lung functions were taken cancersupport at days 45, 150 and 180 from baseline. Eight of the 9 subjects had reduced IgE. 2 In 1989 open label studies at two sites in Riverside County, CA in 1989. Sixteen of the 17 subjects cancersupport had lowered IgE levels from Day 0 to Day 30.3
Click here - your most complete directory for cancer information and medications
| cancersymptoms | cancertherapy | cancertreatment | cancertreatments |
| cancervaccines |
2003 cancer-site.com.
All Rights Reserved. The products mentioned are trademarks of their respective owners and are not owned by us. Read our privacy guidelines.